Literature DB >> 7037509

Contractile activity and prostacyclin generation in isolated coronary arteries from diabetic dogs.

L Sterin-Borda, E S Borda, M F Gimeno, M A Lazzari, E del Castillo, A L Gimeno.   

Abstract

The present study was aimed at determining the generation of "prostacyclin (PGI2)-like-material" in coronary arteries from normal and diabetic (pancreatectomized) dogs as well as the contractile responses to prostacyclin of preparations from normal, diabetic and insulin-treated diabetic animals. PGI2 produced a dose-dependent relaxation of coronary arteries from normal dogs. In contrast, those from diabetic animals were not related; indeed, at low concentrations PGI2 failed to evoke any effect but at higher ones it induced a distinct contraction. In arteries from diabetic animals treated with insulin, PGI2 induced a biphasic contractile effect, which lay between that of normal controls and untreated diabetics. In addition the basal generation of "PGI2-like-material" by coronary arteries was significantly higher in the diabetic (141 +/- 0.2 pg/mg, mean +/- SEM) than in normal dogs (59 +/- 0.2 pg/mg). The present experiments demonstrate that the generation of "PGI2-like substance" is significantly increased in coronary arteries from diabetic dogs, but the same vessels are unable to respond to added authentic PGI2 with relaxation; on the contrary they react with a distinct positive contractile response.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7037509     DOI: 10.1007/bf00253871

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  25 in total

1.  Prostacyclin (PGI2) decreases the cyclic AMP level in coronary arteries.

Authors:  K Schrör; P Rösen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-01       Impact factor: 3.000

2.  Effect of prostacyclin on myogenic activity and adrenergic neuroeffector interaction in isolated canine veins.

Authors:  A G Herman; T J Verbeuren; S Moncada; J R Vane; P M Vanhoutte
Journal:  Arch Int Pharmacodyn Ther       Date:  1978-04

3.  The effect of prostacyclin on the human umbilical artery.

Authors:  K Pomerantz; A Sintetos; P Ramwell
Journal:  Prostaglandins       Date:  1978-06

4.  Recirculation of prostacyclin (PGI2) in the dog.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Br J Pharmacol       Date:  1978-10       Impact factor: 8.739

5.  Transformation of arachidonic acid and prostaglandin endoperoxides by the guinea pig heart. Formation of RCS and prostacyclin.

Authors:  K Schrör; S Moncada; F B Ubatuba; J R Vane
Journal:  Eur J Pharmacol       Date:  1978-01-01       Impact factor: 4.432

6.  Increased prostacyclin release from perfused hearts of acutely diabetic rats.

Authors:  P Rösen; K Schrör
Journal:  Diabetologia       Date:  1980-05       Impact factor: 10.122

7.  Prostacyclin (PGX) is the endogenous metabolite responsible for relaxation of coronary arteries induced by arachindonic acid.

Authors:  G J Dusting; S Moncada; J R Vane
Journal:  Prostaglandins       Date:  1977-01

8.  Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation.

Authors:  S Moncada; E A Higgs; J R Vane
Journal:  Lancet       Date:  1977-01-01       Impact factor: 79.321

9.  Human platelet rich plasma and human serum protects from inactivation the antiaggregatory capacity of prostacyclin-like material (PGI2) produced by the rat stomach fundus.

Authors:  E S Borda; M A Lazzari; M F Gimeno; A L Gimeno
Journal:  Prostaglandins       Date:  1980-06

10.  Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries.

Authors:  M F Gimeno; L Sterin-Borda; E S Borda; M A Lazzari; A L Gimeno
Journal:  Prostaglandins       Date:  1980-06
View more
  6 in total

1.  Contractile activity and prostacyclin generation in isolated coronary arteries from diabetic dogs.

Authors:  D P Mikhailidis; J Y Jeremy; P Dandona
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122

2.  Involvement of thromboxane and leukotriene in arachidonate induced coronary constriction in diabetic rats.

Authors:  Y Takiguchi; K Umemura; H Hashimoto; M Nakashima
Journal:  Diabetologia       Date:  1989-06       Impact factor: 10.122

3.  Role of vascular adrenergic mechanisms in the haemodynamic and PGI2 stimulating effects of angiotensin in diabetic dogs.

Authors:  M Z Koltai; I Pósa; E Kocsis; P Rösen; G Pogátsa
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

4.  Relationship between vascular adrenergic receptors and prostaglandin biosyntheses in canine diabetic coronary arteries.

Authors:  M Z Koltai; P Rösen; P Hadházy; G Ballagi-Pordány; A Köszeghy; G Pogátsa
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

5.  Vascular responsiveness and eicosanoid production in diabetic rats.

Authors:  D M Roth; D K Reibel; A M Lefer
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

6.  Is prostacyclin subserving a vasodilator effect of methoxamine involving alpha adrenoreceptors?

Authors:  E Borda; L Sterin-Borda; M F Gimeno; M Lazzari; A L Gimeno
Journal:  Experientia       Date:  1983-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.